Amsterdam Gastroenterology Endocrinology Metabolism
-
Not all DOACs are created equal, revisiting the safety of rivaroxaban for the prevention of portal hypertension-related complications
Bot, K. K. I. M., Ezzafzafi, S. & Lantinga, M. A., 5 Aug 2025, (E-pub ahead of print) In: Journal of Hepatology.Research output: Contribution to journal › Article › Academic
- All publications